loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Poly L Lactide? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    View Presentation

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Nomisma Healthcare

    filter clear-filterReset all filters

    PharmaCompass

    01

    Nomisma Healthcare

    PLLA-PEG

    arrow
    China Battery Fair
    Not Confirmed

    02

    Nomisma Healthcare

    PLLA

    arrow
    China Battery Fair
    Not Confirmed

    Nomisma Healthcare

    India
    arrow
    China Battery Fair
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    Brand Name : PLLA

    Application : Controlled & Modified Release

    Excipient Details : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Ingredient(s) : Poly L Lactide

    Dosage Form : Tablet

    Grade : Oral, Parenteral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Poly L Lactide

    Dosage Form : Tablet

    Category : Controlled & Modified Release

    Brand : PLLA

    Applications : PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.

    Pharmacopoeia Ref : NA

    Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

    Grade : Oral, Parenteral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth